GR1000117B - Χρηση μεταλλοπορφυρινων για αναστροφη της τοξικης δρασης της θεραπειας ογκων. - Google Patents

Χρηση μεταλλοπορφυρινων για αναστροφη της τοξικης δρασης της θεραπειας ογκων.

Info

Publication number
GR1000117B
GR1000117B GR880100589A GR880100589A GR1000117B GR 1000117 B GR1000117 B GR 1000117B GR 880100589 A GR880100589 A GR 880100589A GR 880100589 A GR880100589 A GR 880100589A GR 1000117 B GR1000117 B GR 1000117B
Authority
GR
Greece
Prior art keywords
metalloporfyrines
inversion
toxic activity
tumors treatment
treatment
Prior art date
Application number
GR880100589A
Other languages
Greek (el)
English (en)
Other versions
GR880100589A (en
Inventor
S George Drummond
Attallah Kappas
S Paul Wissel
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of GR880100589A publication Critical patent/GR880100589A/el
Publication of GR1000117B publication Critical patent/GR1000117B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR880100589A 1987-09-08 1988-09-09 Χρηση μεταλλοπορφυρινων για αναστροφη της τοξικης δρασης της θεραπειας ογκων. GR1000117B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9381787A 1987-09-08 1987-09-08

Publications (2)

Publication Number Publication Date
GR880100589A GR880100589A (en) 1989-06-22
GR1000117B true GR1000117B (el) 1991-06-28

Family

ID=22240903

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100589A GR1000117B (el) 1987-09-08 1988-09-09 Χρηση μεταλλοπορφυρινων για αναστροφη της τοξικης δρασης της θεραπειας ογκων.

Country Status (10)

Country Link
EP (1) EP0333831B1 (de)
JP (1) JPH02501740A (de)
KR (1) KR890701108A (de)
AT (1) ATE78164T1 (de)
AU (1) AU603938B2 (de)
DE (1) DE3872871T2 (de)
DK (1) DK225689D0 (de)
ES (1) ES2012547A6 (de)
GR (1) GR1000117B (de)
WO (1) WO1989002269A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
BR9507643A (pt) * 1994-05-13 1997-09-23 Monsanto Co Métodos de uso para catalisadores de decomposição de peroxinitrito composições farmacéuticas para os mesmos
GB9606293D0 (en) * 1996-03-26 1996-05-29 William Harvey Research Limite Treatment of cancers and other tumours
JP4743673B2 (ja) 1999-04-30 2011-08-10 プロゲン ファーマシューティカルズ， インコーポレイテッド ポリアミンおよび治療におけるそれらの使用
US7375216B2 (en) 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
US7960371B2 (en) * 2006-10-04 2011-06-14 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
PL2691398T3 (pl) 2011-03-30 2017-07-31 Infacare Pharmaceutical Corporation Sposoby syntezy mezoporfiryn metali

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386087A (en) * 1981-07-01 1983-05-31 Research Foundation Of The City University Of New York N-Substituted metalloporphyrins as anti-tumor agents against PS-P-388(P388) leukemia in animals
DE8506853U1 (de) * 1985-03-08 1985-10-10 Neumeier, Robert, 8183 Rottach-Egern Verschlußkopf eines aufblasbaren Luftballons
US4668670A (en) * 1986-06-20 1987-05-26 The Rockefeller University Tin diiododeuteroporphyrin and therapeutic use thereof
US4692439A (en) * 1986-06-20 1987-09-08 The Rockefeller University Therapeutic use of tin diiododeuteroporphyrin
US4782049A (en) * 1986-12-08 1988-11-01 The Rockefeller University Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis

Also Published As

Publication number Publication date
EP0333831A4 (de) 1990-06-26
DK225689A (da) 1989-05-08
WO1989002269A1 (en) 1989-03-23
ATE78164T1 (de) 1992-08-15
AU603938B2 (en) 1990-11-29
GR880100589A (en) 1989-06-22
DE3872871D1 (de) 1992-08-20
EP0333831B1 (de) 1992-07-15
JPH02501740A (ja) 1990-06-14
ES2012547A6 (es) 1990-04-01
KR890701108A (ko) 1989-12-19
DE3872871T2 (de) 1992-12-03
AU2525488A (en) 1989-04-17
DK225689D0 (da) 1989-05-08
EP0333831A1 (de) 1989-09-27

Similar Documents

Publication Publication Date Title
ATE87214T1 (de) Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
DE68912334D1 (de) Immunokonjugate für krebs-diagnose und -therapie.
AU5299393A (en) Low-power x-ray source with implantable probe for treatment of brain tumors
IT8027029A0 (it) Complessi platino-diamminici e formulazioni farmaceutiche per il trattamento del cancro che licontengono.
AU1808488A (en) Compounds for the treatment of alzheimer's disease
GB8824869D0 (en) Synthetic antibody
BG42837A3 (bg) Метод за получаване на имуноглобулинови производни на винка алкалоиди
DE69202441D1 (de) Melatoninderivate und Kombinationen mit Antiestrogenen zur Behandlung von Brustkarzinoma.
GR880100589A (en) Metalloporfyrines for the inversion of the toxic activity for the tumors treatment
ZA92663B (en) Pharmaceutical formulation for treating and/or diagnosing soft tissue tumors.
NO880908L (no) Kombinasjonsterapi med bruk av antitumor immunotoksiner med tumornekrosefaktor.
ZA877901B (en) Active compounds for use in the treatment of tumors
DE3684953D1 (de) Verwendung einer waessrigen chloritmatrix-loesung zur herstellung von arzneimitteln zur intravenoesen behandlung von tumoren.
EP0285906A3 (en) Active agent for combating tumours
ES2040765T3 (es) Procedimiento para preparar un agente para el tratamiento de enfermedades angiogenas o tumores.
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ZA88922B (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
DE3879709D1 (de) Platin-arzneimittel.
NO883040L (no) Middel for undersoekelse av tumorer, samt fremgangsmaate for fremstilling av et slikt middel.
ES2118758T3 (es) Composiciones y metodo para tumores de tejidos blandos.
BG34201A1 (en) Method for potentiating the effect of cytostatic agents in chemical treatment of cancer
IT1232761B (it) Cura chimica del cancro del castagno mediante iniezione o per via corticale
UA30636A (uk) Спосіб лікування виразки шлунка й дванадцятипалої кишки та пристрій для його здійснення
IT1218656B (it) Impiego di composti aventi attivita' mitogena in terapia citostatica